Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative diabetic retinopathy. Medscape Medical News
Category: News
Night Shift: Raised Head in Bed May Worsen Glaucoma
Patients with primary open-angle glaucoma were found to have lower blood flow to the eye during sleep, which may contribute to the progression of the eye disorder. Medscape Medical News
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. WebMD Health News
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it will hold a virtual Special Meeting on April 16, 2025, at which stockholders will vote on a proposal for the liquidation …
New Tool May Flag Visual Perception Problems Post-Stroke
The free tool takes 15 minutes to administer and could increase screening access for stroke survivors and fill an unmet need for health care professionals. Medscape Medical News
Can Hypertension Be Protective Against Glaucoma in Blacks?
A study of people of African ancestry confirmed myopia raises the risk for conversion to primary open-angle glaucoma, but hypertension appeared to lower the risk. Medscape Medical News
There’s a Sandwich Bag of Plastic in Your Brain
Dr F. Perry Wilson reviews disturbing data about the accumulation of nanoplastics in the human body. Medscape
Rosacea: Newer Approaches to Diagnosis, Management
Natural compounds are on the menu, while heparan sulfate analogs may be coming. Medscape Medical News
Preservative-Free Glaucoma Drops Improve IOP and Eye Health
Switching to preservative-free glaucoma drops significantly lowers intraocular pressure and improves ocular surface disease in a recent study. Medscape News UK
Alcon Canada renforce son engagement envers les patients atteints d’astigmatisme en offrant les lentilles cornéennes TOTAL30 pour l’astigmatisme dans de nouveaux paramètres élargis
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui l’ajout de paramètres élargis à la gamme de lentilles TOTAL30MD pour l’as…
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Wat…
STAAR Surgical Announces Leadership Transition
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farr…
ForSight Robotics Achieves ISO 13485:2016 Certification
YOKNEAM ILLIT, Israel–(BUSINESS WIRE)– #ISOCertification–ForSight Robotics achieves ISO 13485:2016 certification, an international benchmark for quality management systems in the medical device industry.
Fed Health Centers Poised to Expand Eye Care, Lose Funding
A systematic analysis finds Federally Qualified Health Centers can and should do more to expand vision care services, just as a funding crisis threatens to shrink their scope. Medscape Medical News
Will Pharma Continue Efforts to Diversify Clinical Trials?
The federal crackdown on DEI initiatives is unlikely to deter companies from designing more representative trials, as it’s ‘good science, good ethics, and good business,’ one expert said. Medscape Medical News
Thalidomide May Prevent IgG4-RD Relapse Without Steroids
Thalidomide shows promise as a steroid-sparing option for IgG4-related disease, with a significant reduction in relapse rates and enhanced remission, according to a placebo-controlled study. Medscape Medical News
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
ZÜRICH–(BUSINESS WIRE)–CDR-Life today announced the achievement of the fifth milestone under its collaboration and licensing agreement with Boehringer Ingelheim in the advancement of BI 771716, a novel therapeutic candidate for the treatment of geogr…
Study Finds No Vision Issues in Children With Vitiligo
Children with vitiligo do not have a higher risk for visual acuity deficits than healthy peers, a study suggests. Medscape Medical News